GVAG
GILD icon

Great Valley Advisor Group’s Gilead Sciences GILD Stock Holding History

Great Valley Advisor Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$649K Sell
5,138
-279
-5% -$36.8K 0.01% 638
2026
Q1 		$755K Buy
5,417
+247
+5% +$34.6K 0.01% 565
2025
Q4 		$635K Buy
5,170
+271
+6% +$32.9K 0.01% 572
2025
Q3 		$543K Sell
4,899
-297
-6% -$33.8K 0.01% 609
2025
Q2 		$576K Sell
5,196
-797
-13% -$84.8K 0.01% 575
2025
Q1 		$672K Buy
5,993
+39
+0.7% +$4.02K 0.01% 524
2024
Q4 		$550K Buy
5,954
+391
+7% +$35.2K 0.01% 558
2024
Q3 		$467K Sell
5,563
-431
-7% -$32.9K 0.01% 578
2024
Q2 		$411K Sell
5,994
-1,266
-17% -$84.5K 0.01% 574
2024
Q1 		$532K Sell
7,260
-435
-6% -$33.5K 0.02% 485
2023
Q4 		$623K Sell
7,695
-4,129
-35% -$321K 0.02% 413
2023
Q3 		$886K Buy
11,824
+1,959
+20% +$151K 0.04% 337
2023
Q2 		$760K Buy
9,865
+238
+2% +$19K 0.03% 355
2023
Q1 		$799K Buy
9,627
+2,633
+38% +$218K 0.04% 340
2022
Q4 		$600K Sell
6,994
-208
-3% -$16.5K 0.03% 409
2022
Q3 		$444K Sell
7,202
-179
-2% -$11.3K 0.02% 446
2022
Q2 		$456K Sell
7,381
-3,459
-32% -$214K 0.03% 447
2022
Q1 		$648K Sell
10,840
-359
-3% -$22.9K 0.04% 349
2021
Q4 		$811K Buy
11,199
+12
+0.1% +$827 0.05% 298
2021
Q3 		$781K Sell
11,187
-613
-5% -$43.1K 0.05% 275
2021
Q2 		$810K Buy
11,800
+15
+0.1% +$1K 0.06% 260
2021
Q1 		$762K Sell
11,785
-2,617
-18% -$169K 0.07% 233
2020
Q4 		$839K Sell
14,402
-42,790
-75% -$2.58M 0.09% 202
2020
Q3 		$3.61M Buy
57,192
+497
+0.9% +$34.5K 0.44% 55
2020
Q2 		$4.36M Buy
56,695
+11,137
+24% +$854K 0.71% 30
2020
Q1 		$3.41M Buy
45,558
+32,070
+238% +$2.22M 0.9% 26
2019
Q4 		$877K Sell
13,488
-731
-5% -$47.6K 0.2% 149
2019
Q3 		$901K Buy
14,219
+1,546
+12% +$101K 0.22% 137
2019
Q2 		$856K Buy
12,673
+502
+4% +$33K 0.22% 141
2019
Q1 		$791K Sell
12,171
-4,056
-25% -$270K 0.25% 118
2018
Q4 		$1.01M Buy
+16,227
New +$1.13M 0.38% 69

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Great Valley Advisor Group's GILD Position: Q2 2026 in Review

Great Valley Advisor Group reduced its Gilead Sciences (GILD) stake by 5.2% in Q2 2026, selling an estimated $36.8K and leaving 5,138 shares worth $649K. The position accounts for 0.01% of the portfolio, ranked #638.

Great Valley Advisor Group first reported a position in GILD in Q4 2018 and has held it in 31 quarters since. The position peaked at $4.36M in Q2 2020. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Great Valley Advisor Group held 5,138 shares of Gilead Sciences worth $649K as of Q2 2026.
  • Great Valley Advisor Group sold 279 Gilead Sciences shares in Q2 2026, an estimated $36.8K.
  • Gilead Sciences made up 0.01% of Great Valley Advisor Group's portfolio in Q2 2026, its #638 holding.
  • Great Valley Advisor Group first reported a position in Gilead Sciences in Q4 2018 and has held it in 31 quarters since.
  • Great Valley Advisor Group's Gilead Sciences position peaked at $4.36M in Q2 2020.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Great Valley Advisor Group's 13F filing for Q2 2026, filed 10 Aug 2026.